Biomarin Pharmaceutical Inc (NAS:BMRN)
$ 65.42 0.54 (0.83%) Market Cap: 12.47 Bil Enterprise Value: 12.14 Bil PE Ratio: 39.17 PB Ratio: 2.30 GF Score: 72/100

Biomarin Pharmaceutical Inc at Piper Sandler Healthcare Conference (Virtual) Transcript

Dec 02, 2021 / 06:30PM GMT
Release Date Price: $84.68 (+0.21%)
Christopher Joseph Raymond;Jean;Jacques
Piper Sandler & Co., Research Division - MD & Senior Research Analyst

Great. Well, let's go ahead and get started with our next session. Thanks, everybody, for dialing in. This is the last day, I believe, of the Piper Sandler 33rd Annual Healthcare Conference. I appreciate everybody dialing in.

We have with us our next presenter, which is BioMarin. We have with us Chairman and CEO, J.J. Bienaime; CFO, Brian Mueller; and Chief Commercial Officer, Jeff Ajer.

So this is meant to be a participative session. So folks, I think there's an option for you in your Zoom window to ask a question, if you want to raise your hand and ask a question, that way you can do it or if you don't want to do it that way, there's always the old school option. You can just e-mail me. Hit me an e-mail, and I'll make sure your question gets answered.

So J.J., I think you had a couple of minutes of intro commentary that you wanted to make. So I'll let you do that. Please take it away, and then we'll jump into questions.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot